Verrica Pharmaceuticals Inc.
VRCA
$5.19
-$0.07-1.33%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 11.20M | 20.60M | 30.15M | 21.10M | 15.40M |
| Total Receivables | 11.09M | 7.81M | 5.40M | 7.33M | 17.37M |
| Inventory | 2.71M | 1.97M | 2.24M | 2.30M | 2.52M |
| Prepaid Expenses | 2.62M | 2.37M | 2.80M | 3.59M | 1.49M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 5.02M | 1.37M | 1.96M | 1.96M | -- |
| Total Current Assets | 32.64M | 34.13M | 42.54M | 36.28M | 36.78M |
|
|
|||||
| Total Current Assets | 32.64M | 34.13M | 42.54M | 36.28M | 36.78M |
| Net Property, Plant & Equipment | 2.03M | 1.66M | 1.86M | 1.89M | 1.95M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1.34M | 2.99M | 2.73M | 2.73M | 376.00K |
| Total Assets | 36.02M | 38.79M | 47.13M | 40.90M | 39.11M |
|
|
|||||
| Total Accounts Payable | 1.60M | 2.19M | 2.07M | 1.59M | 2.32M |
| Total Accrued Expenses | 4.14M | 3.01M | 4.03M | 3.88M | 3.13M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 956.00K | 744.00K | 746.00K | 13.16M | 13.32M |
| Total Finance Division Other Current Liabilities | 15.75M | 10.27M | 9.59M | 10.28M | 10.46M |
| Total Other Current Liabilities | 15.75M | 10.27M | 9.59M | 10.28M | 10.46M |
| Total Current Liabilities | 22.44M | 16.22M | 16.44M | 28.91M | 29.22M |
|
|
|||||
| Total Current Liabilities | 22.44M | 16.22M | 16.44M | 28.91M | 29.22M |
| Long-Term Debt | -- | -- | -- | 21.62M | 24.58M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 854.00K | 698.00K | 885.00K | 959.00K | 995.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 8.41M | 5.81M | 5.07M | 6.45M | 1.80M |
| Total Liabilities | 31.71M | 22.73M | 22.39M | 57.94M | 56.59M |
|
|
|||||
| Common Stock & APIC | 352.06M | 350.65M | 349.66M | 299.80M | 299.08M |
| Retained Earnings | -347.75M | -334.60M | -324.91M | -316.84M | -316.57M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 4.31M | 16.06M | 24.74M | -17.04M | -17.48M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 4.31M | 16.06M | 24.74M | -17.04M | -17.48M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 4.31M | 16.06M | 24.74M | -17.04M | -17.48M |
|
|
|||||